Keyphrases
Pancreatic Adenocarcinoma
100%
Carbohydrate Antigen 19-9 (CA19-9)
100%
Response to Neoadjuvant Therapy
100%
Neoadjuvant Therapy
33%
Borderline Resectable
33%
Pancreatic Ductal Adenocarcinoma
22%
Overall Survival
22%
R0 Resection
22%
R0 Resection Rate
22%
Clinical Trials
11%
Survival Prediction
11%
Hazard Ratio
11%
Kaplan-Meier
11%
Odds Ratio
11%
Fisher's Exact Test
11%
Locally Advanced Disease
11%
Multivariate Analysis
11%
Survival Analysis
11%
Response Rate
11%
Pathological Complete Response
11%
Cox Regression
11%
Prognostic Marker
11%
Venous Resection
11%
Resectable Disease
11%
Histological Response
11%
Resection Rate
11%
Rapid Evaluation
11%
Novel Regimens
11%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Neoadjuvant Therapy
100%
CA 19-9 Antigen
100%
Surgery
66%
Disease
22%
Overall Survival
22%
Biological Marker
11%
Hazard Ratio
11%
Odds Ratio
11%
Clinical Trial
11%
Fisher Exact Test
11%
Multivariate Analysis
11%
Proportional Hazards Model
11%
Survival Analysis
11%